Search

everythinglearnresearchcommunity

for

Search:↓

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

Suppressing ODC activity reduces tumor growth in hair follicles.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

DGAT1 enzyme helps make diacylglycerols, waxes, and retinyl esters.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

The enzyme system in hair follicles is similar to the liver's and is affected by certain inhibitors.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Introducing the rat OTC gene partially corrected OTC deficiency in mice.

Transamidases are present in the epidermis but their exact role is unclear.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

A new enzyme in rats may help regulate hair growth.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Both enzyme forms can sulfate minoxidil.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.